Best practice for prescribing drugs with dependence potential An overview of the considerations for prescribing medicines with the risk of dependency, including monitoring, discontinuation and the optimisation of therapeutic outcomes.…
ICBs funded for independent prescribing implementation NHS England has published three documents relating to community pharmacist prescribing in 2026/2027.…
Prescribing of dependency forming medicines ‘moving in the right direction’ but challenges remain NHS Business Services Authority data reveals that in 2025/2026, the number of prescriptions for opioids decreased by 8% compared with 2016/2017.…
Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Community pharmacists most confident in minor ailment prescribing, survey suggests A National Pharmacy Association survey found that nearly three-quarters of pharmacists felt that using prescribing to manage minor acute illnesses was the area that added most value.…
The pharmacist’s role in optimising care for adults with trigeminal neuralgia This article offers an overview of the clinical features and pharmacological management of trigeminal neuralgia, as well as ways in which pharmacists can provide holistic care for patients.…
Coroner raises concerns over lack of national guidance on prescribing for hepatitis B reactivation A patient died from complications from reactivation of hepatitis B, after the supply of viral reactivation prophylaxis was inadvertently discontinued.…
Electronic prescription service: the battle for nominations Allegations that electronic prescription service nominations are being switched without patients’ consent have prompted concerns over safety. The Pharmaceutical Journal investigates the potential impact.…
ADHD medicines prescriptions rose again in 2025 More than 991,000 items of lisdexamfetamine were prescribed in NHS primary care in 2025, which is a 36% increase compared with 2024, according to Care Quality Commission data.…
The GPhC must demonstrate equivalence before shortening the international registration route Why a faster, more flexible prescribing qualification route can only be justified if the General Pharmaceutical Council demonstrates that it delivers the same standards, responsibilities and public confidence as the existing pathway.…
